Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-030514

Chief Financial Officer acquired 1,586 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2022-09-01 Grant or award +793 $25.98 $20,602 793 D: show line 1 in the form
Mokari Atabak Chief Financial Officer 2022-09-01 Grant or award +793 1,586 D: show line 2 in the form
Loading xslF345X03/doc4.xml…